HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
12.48
-0.16 (-1.27%)
Aug 19, 2026, 2:01 PM EDT - Market open
HUTCHMED (China) Employees
HUTCHMED (China) had 1,790 employees as of June 30, 2026.
Employees
1,790
Change
n/a
Growth
n/a
Revenue / Employee
$306,772
Profits / Employee
$9,991
Market Cap
2.22B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1,790 | - | - |
| Dec 31, 2025 | 1,796 | -15 | -0.83% |
| Dec 31, 2024 | 1,811 | -177 | -8.90% |
| Dec 31, 2023 | 1,988 | -37 | -1.83% |
| Dec 31, 2022 | 2,025 | 265 | 15.06% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,100 |
| Trulieve Cannabis | 5,000 |
| ANI Pharmaceuticals | 970 |
| Prestige Consumer Healthcare | 890 |
| Supernus Pharmaceuticals | 778 |
| BioCryst Pharmaceuticals | 435 |
| Xeris Biopharma Holdings | 435 |
HCM News
- 2 days ago - HUTCHMED's ORPATHYS-TAGRISSO Combo Shows Significant PFS, OS Benefit In Phase III Trial - Nasdaq
- 2 days ago - Hutchmed announces results from Saffron Phase III trial of Orpathys, Tagrisso - TheFly
- 2 days ago - HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO® - GlobeNewsWire
- 20 days ago - HUTCHMED H1 Earnings Call Highlights - MarketBeat
- 20 days ago - HUTCHMED (China) Earnings Call Transcript: H1 2026 - Transcripts
- 20 days ago - HUTCHMED (China) Quarterly report: H1 2026 - Filings
- 20 days ago - HUTCHMED (China) Slides: H1 2026 - Filings
- 27 days ago - Hutchmed price target lowered to $14 from $16 at Goldman Sachs - TheFly